by Jordana Choucair | Nov 29, 2022 | M&A
AstraZeneca PLC announced it will acquire Neogene Therapeutics Inc. in a deal worth up to $320 million, growing the company’s oncology portfolio. The transaction is expected to close in the first quarter of 2023, subject to customary closing conditions and...
by Jordana Choucair | Nov 29, 2022 | M&A
Boston Scientific announced it entered a definitive agreement to acquire Apollo Endosurgery for a cash price of $10 per share to reflect an enterprise value of approximately $615 million. Apollo Endosurgery anticipates net sales of approximately $76 million in the...
by Jordana Choucair | Nov 29, 2022 | Opioid/Substance Use Disorders
The Department of Health and Human Services (HHS) proposed a rule to align 42 CFR Part 2 privacy protections with HIPAA. The rule would require one-time patient consent for disclosure of treatment and allowing HIPAA-covered entities to access those records. The rule...
by Jordana Choucair | Nov 29, 2022 | Transition to Value
Recently released data from the Centers for Medicare & Medicaid Services (CMS) found the Direct Contracting Model saved Medicare $70 million in 2021, the first year the model took effect. The data shows that 53 direct contracting entities generated savings for...
by Jordana Choucair | Nov 28, 2022 | Access & Coverage
A federal lawsuit in Texas is challenging the Affordable Care Act’s (ACA) requirement for insurers to cover preventative health services. A district court judge in September ruled that the way certain preventive services are determined to be covered was...
by Jordana Choucair | Nov 28, 2022 | Public Health/Prevention
The World Health Organization (WHO) said that it will phase out the use of “monkeypox” and replace it with “mpox” after the scientific community asked for a new name to avoid stigmatization that can be associated with infection. In a statement,...
Recent Comments